Munich Re : A trend reversal is underway
Entry price | Target | Stop-loss | Potential |
---|
€174.7 |
€160.65 |
€179.15 |
+8.04% |
---|
Muenchener Rueckversicherungs-Ges. AG's shares show signs of a reversal to the downside. The technical chart pattern has deteriorated and suggests a continuation of the decline.
Summary● In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
Strengths● Its low valuation, with P/E ratio at 10.76 and 11.26 for the ongoing fiscal year and 2017 respectively, makes the stock pretty attractive with regard to earnings multiples.
● This company will be of major interest to investors in search of a high dividend stock.
● Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at EUR 184.65.
● The stock is close to a major daily resistance at EUR 179.15, which should be gotten rid of so as to gain new appreciation potential.
● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.